• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

BIOMARKER R&D PROJECTS

  • 1124-light-pink.png

    PACIFIC

    Re-defining heart failure with preserved ejection fraction (HFpEF)

  • 1124-light-grey.png

    MemoryLiNC

    Validating clinical diagnostic performance of the best non-coding RNA panel to enable the diagnosis of early Alzheimer’s Disease

  • 1124-light-red.png

    HeartLiNC

    innovative IVD test to assess the risk of developing heart failure after acute myocardial infarction based on a unique profile of long non-coding RNAs

  • 1124-light-purple.png

    NOVACARE

    a novel therapeutic antibody and a companion diagnostic test for non-ischaemic cardiac remodeling

  • 1124-light-blue.png

    SECRETONET

    Developing new diagnostic and targeted therapeutic tools for neuroendocrine tumors

  • 1124-light-yellow.png

    ADDIA

    a reliable and non-invasive blood test for early diagnosis of Alzheimer's Disease

  • 1124-light-green.png

    RABIOPRED

    developing biomarkers to predict response to TNF-α inhibitors treatment of Rheumatoid Arthritis

  • 33-ev1xqevl2wi.jpg

    Looking for a Research Collaboration?

    sharing expertise to establish and fund innovative research projects

  • investing very significantly in biomarker r&d projects since 2009, today,

    Firalis is a constantly sought r&d partner, including European research consortia as :

    The Coordinator,

    For the European Community grants in particular, Firalis has an extensive experience from the creation of project proposals including all technical, financial and commercial aspects, to establishment of a research consortium, and  in all administrative steps, from project submission to overall financial and administrative coordination.

     

    a Participant,

    As a European leader SME in biomarkers and biomarker-related non-invasive diagnostic solutions, we carefully select a limited number of new projects, where we are invited to join as a project participant for European grants. We prioritize cardiovascular and neurology fields according to our core interest, and take place in few respectful consortia each year.

     

    or a Subcontractor.

    Thanks to our laboratories equipped with cutting-edge technology platforms and related technical know-how, researchers and trained technicians, also with our biobank service, altogether operating under a highest quality environment certified and accredited; Firalis is also a unique CRO service provider for all biomarker research projects.

    an ACADEMIC INSTITUTE
    willing to convert an IP into a product?


    a PHARMA COMPANY
    to subcontract a biomarker validation study?


    or an SME COMPANY
    looking for a partner in biomarker qualification?

    SUBMIT YOUR R&D COLLABORATION REQUEST

    Contact Firalis

    Firalis Group

    © Copyright 2020 all rights reserved. 

    The company logos, products and service marks are trademarks or registered trademarks of Firalis.

    -----------------------------------------------------------------------------------------------------------------------

    Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

    -----------------------------------------------------------------------------------------------------------------------

    Headquarter : 17 Rue du Fort 68330 Huningue FRANCE